Cart
sales@molnova.com
Home - Products - Angiogenesis - VEGFR - AG-13958

AG-13958

CAS No. 319460-94-1

AG-13958( AG-013958 )

Catalog No. M20778 CAS No. 319460-94-1

AG-13958 (AG-013958) a potent VEGFR tyrosine kinase inhibitor for the treatment of age-related macular degeneration.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 275 In Stock
5MG 264 In Stock
10MG 407 In Stock
25MG 655 In Stock
50MG 923 In Stock
100MG 1228 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    AG-13958
  • Note
    Research use only, not for human use.
  • Brief Description
    AG-13958 (AG-013958) a potent VEGFR tyrosine kinase inhibitor for the treatment of age-related macular degeneration.
  • Description
    AG-13958 (AG-013958) a potent VEGFR tyrosine kinase inhibitor for the treatment of age-related macular degeneration.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    AG-013958
  • Pathway
    Angiogenesis
  • Target
    VEGFR
  • Recptor
    VEGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    319460-94-1
  • Formula Weight
    467.5
  • Molecular Formula
    C26H22FN7O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:5 mg/mL (10.70 mM)
  • SMILES
    Cc1cc(C(=O)Nc2cc(Nc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)ccc2F)n(C)n1
  • Chemical Name
    N-[2-Fluoro-5-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]amino]phenyl]-13-dimethyl-1H-pyrazole-5-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Barakat M R Kaiser P . VEGF inhibitors for the treatment of neovascular age-related macular degeneration[J]. Expert Opinion on Investigational Drugs 2009 18(5):637-646.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Cabozantinib (S-mala...

    Cabozantinib (XL184) is a potent, multi-kinase inhibitor that inhibits VEGFR2, c-Met, Kit, Axl and Flt3 with IC50 of 0.035, 1.3, 4.6, 7 and 11.3 nM, respectively.

  • Fargesin

    Fargesin as a potential β1AR antagonist through cAMP/PKA pathway could protect against myocardial ischemia/reperfusion injury in rats.

  • Ellipticine

    Ellipticine is a potent antineoplastic agent exhibiting multiple mechanisms of action.

Sign In Join Free